| 11.3 0.13 (1.16%) | 07-23 11:49 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Kindly MD, Inc. functions as a diversified enterprise involved in both direct healthcare delivery and the management of health-related data. The company offers patient-focused services that seamlessly integrate traditional prescription medication with essential behavioral health support. It provides a range of specialized outpatient clinical offerings, accessible through either a subscription model or on a fee-for-service basis, designed to enhance and supplement conventional medical practices. Their extensive evaluation and management services cover various areas, including the treatment of chronic pain, functional medicine approaches, cognitive behavioral therapy, and specialized interventions for trauma and addiction. Additionally, Kindly MD provides recovery assistance, overdose prevention education, peer support initiatives, limited urgent care, preventative health consultations, travel health services, and hormone therapy. Beyond its clinical operations, the firm undertakes data collection and research projects, alongside conducting online and email marketing campaigns. The company also engages in the retail sale of health-related products, available both at its physical clinics and through its online platform. Established in 2019 and based in Salt Lake City, Utah, the organization operated as Utah Therapeutic Health Center, LLC until it officially rebranded as Kindly MD, Inc. in March 2022.
Fri, 22 May 2026
Kindly MD (NAKAW) Financials 2026 - Income Statement and Balance Sheet - MarketBeat
Mon, 12 May 2025
KindlyMD Stock Surges To All-Time High After Announcing Merger With Nakamoto To Launch Bitcoin Treasury Strategy - Stocktwits
Mon, 12 May 2025
Trade War Deal: The #1 Trade Setting Up NOW - timothysykes.com
Mon, 12 May 2025
David Bailey and Bitcoin-Native Holding Company Nakamoto Announce Merger with KindlyMD to Establish Bitcoin Treasury - Bitcoin Magazine
Mon, 12 May 2025
David Bailey's Nakamoto Holdings Going Public Via Merger With KindlyMD; Shares Soar 650% - Yahoo Finance
Mon, 12 May 2025
KindlyMD shares skyrocket 250% after merger with Trump crypto advisor David Bailey's bitcoin investment company - CNBC
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|